Lung cancer in HIV infection

Deepthi Mani, Missak Haigentz, David M. Aboulafia

Research output: Contribution to journalReview articlepeer-review

42 Scopus citations

Abstract

Lung cancer is the most prevalent nonAIDS-defining malignancy in the highly active antiretroviral therapy era. Smoking plays a significant role in the development of HIV-associated lung cancer, but the cancer risk is two to four times greater in HIV-infected persons than in the general population, even after adjusting for smoking intensity and duration. Lung cancer is typically diagnosed a decade or more earlier among HIV-infected persons (mean age, 46 years) compared to those without HIV infection. Adenocarcinoma is the most common histological subtype, and the majority of patients are diagnosed with locally advanced or metastatic carcinoma. Because pulmonary infections are common among HIV-infected individuals, clinicians may not suspect lung cancer in this younger patient population. Surgery with curative intent remains the treatment of choice for early-stage disease. Although there is increasing experience in using radiation and chemotherapy for HIV-infected patients who do not have surgical options, there is a need for prospective studies because this population is frequently excluded from participating in cancer trials. Evidence-based treatments for smoking-cessation with demonstrated efficacy in the general population must be routinely incorporated into the care of HIV-positive smokers.

Original languageEnglish (US)
Pages (from-to)6-13
Number of pages8
JournalClinical Lung Cancer
Volume13
Issue number1
DOIs
StatePublished - Jan 2012

Keywords

  • AIDS
  • HAART
  • HIV
  • Non-Hodgkin lymphoma

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Fingerprint Dive into the research topics of 'Lung cancer in HIV infection'. Together they form a unique fingerprint.

Cite this